The chemotherapy induced nausea and vomiting treatment market is set to reach US$ 4,568.8 Mn by 2033 from US$ 2,592.3 Mn in 2021 showcasing progressive growth at a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2025 to 2033.
The insomnia treatment drugs market is set to reach US$ 4,332.4 Mn by 2026 from US$ 2,689.6 Mn in 2017 highlighting balanced growth at a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2018 to 2026. As per the research citing of United Nations (UN) by 2033 the geriatric population suffering with insomnia is going to rise by 56%. Insomnia is caused by factors such as stress, addiction, irregular circadian rhythm, chronic pain etc.
The pigmentation disorders treatment market is set to reach US$ 12,313.2 Mn by 2033 from US$ 6,777.4 Mn in 2021 showcasing a steady growth at a compound annual growth rate (CAGR) of 6.9% during the forecast period from 2025 to 2033. The American Association for Pediatric Ophthalmology and Strabismus (AAPOS) claims that 1 in 17,000 people suffer with some form of Albinism.
The anti-infective drugs market is expected to witness a CAGR of 3.8% during the forecast period of 2025 to 2033, driven by various factors. Anti-infective drugs, also known as antimicrobial drugs, are used to treat infectious diseases caused by bacteria, viruses, fungi, and parasites. These drugs play a crucial role in combating infections and reducing morbidity and mortality rates associated with infectious diseases. This analysis provides a brief overview of the anti-infective drugs market, followed by an in-depth examination of the three key drivers and one restraint impacting the market.
The industrial burners market is set to demonstrate promising growth rate during the forecast period from 2018 to 2026, growing from US$ 18.40 Bn in 2017. Industrial burners are among the most crucial components of any industrial application having thermal process-based production line.
The overall online payment gateways market expected to demonstrate robust growth rate during the forecast period from 2020 to 2028, up from US$ 15.83 Bn in 2019. Payment gateways enable convenient payment process for the consumer choosing to pay through credit/debit cards. With e-commerce industry demonstrating rapid growth over the past few years, online payment gateways have emerged as the backbone for e-commerce industry.
The pancreatic fistula treatment market stood at US$ 2,098.16 Mn in 2021 and projected to exhibit compound annual growth rate (CAGR) of 5.7% during the forecast period from 2025 to 2033. The International Study Group for Pancreatic Fistulas (ISGPF), defines post-operative pancreatic fistula as ‘external fistula with a drain output of any measurable volume after post-operative day three with an amylase level greater than three times the upper limit of the normal serum value’.
The overall RFID readers market expected to demonstrate double digit CAGR during the forecast period from 2025 to 2033. RFID technology has emerged among the most revolutionary elements across numerous applications including retail, industrial manufacturing, transportation, supply chain management, healthcare and various others. Due to its ease of use, reliability and greater detection range, RFID technology has witnessed profound penetration across numerous industry verticals, thereby emerging as replacement for barcodes.
The global poultry health market is expected to reach US$ 11,506.3 Mn by 2026, and exhibit steady compound annual growth rate of 7.1% during the forecast period from 2018 to 2026. Good poultry health management is essential for poultry production since culturing a flock with best genetic potential will not grow efficiently if they are diseased or infected.
The Painful Diabetic Neuropathy Drugs Market is forecasted to grow at a CAGR of 7% during the forecast period of 2025 to 2033. Painful diabetic peripheral neuropathy occurs in approximately 25% of patients with diabetes mellitus who have treated in the office sitting&sedentary lifestyle. It typically causes burning pain, paresthesias& numbness in a stocking-glove pattern that progress from the feet & hands.
The drugs by therapeutic area market covers pharmaceutical products classified according to the diseases and medical conditions they are designed to treat. Major therapeutic areas include oncology, cardiovascular diseases, diabetes and other metabolic disorders, neurological conditions, infectious diseases, respiratory disorders, immunology, gastrointestinal diseases, dermatology, ophthalmology, women’s health and rare diseases. The category includes prescription drugs, generic medicines, biologics, biosimilars, vaccines and advanced therapies.
The wider global pharmaceutical market provides an appropriate benchmark for evaluating growth across therapeutic drug categories. One current industry estimate projects the pharmaceutical market to increase from approximately USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, representing a compound annual growth rate of 6.15%. North America held the largest regional share in 2025, while Asia-Pacific is expected to demonstrate notable growth through 2035.
Market growth is being supported by the increasing prevalence of chronic and age-related diseases. Rising cases of cancer, diabetes, cardiovascular disorders, arthritis, respiratory diseases and neurological conditions are creating sustained demand for effective treatments. Population ageing, lifestyle changes, urbanization and improved access to diagnosis are further expanding the number of patients receiving long-term therapy.
Oncology remains an important area for pharmaceutical research and commercial investment. Development activity includes targeted therapies, immune checkpoint inhibitors, antibody-drug conjugates, cell therapies and personalized cancer treatments. Diabetes and obesity drugs are also recording strong demand, supported by the wider use of GLP-1 and other metabolic treatments. Neurology research is expanding across Alzheimer’s disease, Parkinson’s disease, epilepsy and mental health conditions.
Biologic drugs and biosimilars represent major market trends. Biologics are increasingly used to treat cancer, autoimmune diseases and rare disorders, while biosimilars can improve access after reference-product patent expiry. Pharmaceutical companies are also developing gene therapies, RNA-based medicines and other advanced treatments for conditions with limited existing options.
Precision medicine is influencing drug development across multiple therapeutic areas. Biomarkers, genomic testing and companion diagnostics help identify patients who are more likely to respond to specific medicines. Artificial intelligence is also being used for target identification, clinical-trial planning and analysis of real-world treatment data.
Market expansion may be restrained by high research costs, lengthy clinical development, regulatory uncertainty and drug-pricing pressure. Patent expirations can reduce revenue for branded products, while safety concerns or unsuccessful clinical trials may delay commercial launches. Access and reimbursement remain major challenges for expensive biologics and advanced therapies.
Acute Market Reports provides therapeutic-area drug research covering product classes, disease indications, routes of administration, distribution channels, company pipelines, competitive conditions and regional opportunities. These reports help pharmaceutical companies, investors, healthcare providers and distributors evaluate treatment demand and growth prospects through 2035.